4,4'-Diaminodiphenylmethane


Literature identifierStudy typeTest dosageEffective dosageEndocrine-mediated endpointsSystems-level perturbations
PMID:26116029IVR25 mg/kg 25 mg/kgIncreased serotonin (5-HT) levelsNeurological endocrine-mediated perturbations
IVR25 mg/kg 25 mg/kgAffects estrogen metabolismMetabolic endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
PMID:31100596IVTH10 mg/L 10 mg/LDecreased testosterone levelsReproductive endocrine-mediated perturbations
IVTH10 mg/L 10 mg/LAffects steroidogenesisReproductive endocrine-mediated perturbations
IVTH10 mg/L 10 mg/LDecreased estradiol levelsReproductive endocrine-mediated perturbations
IVTH10 mg/L 10 mg/LIncrease in estradiol/testosterone ratioReproductive endocrine-mediated perturbations
IVTH1 mg/L -No significant effects observed-
IVTH100 mg/L 100 mg/LIncrease in estradiol/testosterone ratioReproductive endocrine-mediated perturbations
IVTH100 mg/L 100 mg/LDecreased estradiol levelsReproductive endocrine-mediated perturbations
IVTH100 mg/L 100 mg/LDecreased testosterone levelsReproductive endocrine-mediated perturbations
IVTH100 mg/L 100 mg/LAffects steroidogenesisReproductive endocrine-mediated perturbations

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.